{"id":"W4224529699","doi":"10.1016/s2352-3026(22)00045-x","title":"Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies","year":2022,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; Genentech; Center for Clinical and Translational Science, Mayo Clinic; U.S. Food and Drug Administration; Medac; Swedish Orphan Biovitrum; Daiichi-Sankyo; Energy Market Authority of Singapore; Pfizer; Incyte; Yorkshire Cancer Research; Bayer Fund; TG Therapeutics; MorphoSys; UCB; National Institutes of Health; Regeneron Pharmaceuticals; Breast Cancer Now; Kræftens Bekæmpelse; Takeda Pharmaceuticals U.S.A.; Novartis; Celgene; Alnylam Pharmaceuticals; Sanofi; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Astellas Pharma; Georgia Clinical and Translational Science Alliance; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Bristol-Myers Squibb; Roche; Astellas Pharma US; Daiichi Sankyo Europe; National Cancer Institute; Servier; Gilead Sciences","keywords":"Adverse effect; Context (archaeology); Clinical trial; Cancer; Hematology; Patient safety","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1211347,0.001268637,0.004501567,0.004166361,0.0008273559,0.01237352,0.005219804,0.004172897,0.005606739],"category_scores_gemma":[0.2491385,0.0006967437,0.003091321,0.00449772,0.003558021,0.01455981,0.00656642,0.01294209,0.002046664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004618284,"about_ca_system_score_gemma":0.00720378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008757194,"about_ca_topic_score_gemma":0.01185082,"domain_scores_codex":[0.9001338,0.06113726,0.01793148,0.004106602,0.015064,0.001626753],"domain_scores_gemma":[0.6170835,0.2195114,0.05552154,0.0230912,0.07824301,0.006549228],"domain_codex":null,"domain_gemma":"reporting","domain_candidate":"reporting","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0005510283,0.000195978,0.02604366,0.009784389,0.0006279681,0.00010115,0.001372164,0.001856428,0.001193406,0.01777554,0.069842,0.8706563],"study_design_scores_gemma":[0.0004413544,0.002709661,0.09738961,0.04566126,0.001468274,0.002052929,0.004086077,0.005670593,0.004097456,0.18536,0.6502893,0.0007735709],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"methods","genre_scores_codex":[0.0157086,0.4989907,0.07387093,0.3745851,0.01042988,0.0007371211,0.003871458,0.001395912,0.02041021],"genre_scores_gemma":[0.2473894,0.4128155,0.1704924,0.1308618,0.02684889,0.001119295,0.00439949,0.000745105,0.005328183],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.8788654,"threshold_uncertainty_score":0.6406291,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06402545302891255,"score_gpt":0.3630694404143654,"score_spread":0.2990439873854528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}